Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Functional Eudragit® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis
Chenzhe Gao, Shen Yu, Xiaonan Zhang, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 1405-1422
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment
Yana Gvozdeva, Radiana Staynova
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access | Times Cited: 2
Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems
Hicheme Hadji, Kawthar Bouchemal
Advanced Drug Delivery Reviews (2022) Vol. 181, pp. 114101-114101
Open Access | Times Cited: 67
All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis
Xiangji Yan, Chunhua Yang, Mei Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses
Xiangji Yan, Lingzhang Meng, X. Zhang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1383-1401
Closed Access | Times Cited: 33
Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice
Yingni Lv, Mengjiao Ren, Min Yao, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122741-122741
Closed Access | Times Cited: 32
Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radicals scavenging and controlled neutrophil swarming
Xiangji Yan, Jian Song, Yujie Zhang, et al.
Nano Today (2024) Vol. 54, pp. 102139-102139
Closed Access | Times Cited: 12
Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
Jia Wang, Yuying Shi, Bei Mao, et al.
Applied Materials Today (2024) Vol. 36, pp. 102078-102078
Closed Access | Times Cited: 9
Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathy
H. E. Ramadan, Mahmoud M. A. Elsayed, Amani Elsayed, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100232-100232
Open Access | Times Cited: 8
β-1,3-d-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment
Xiulan Pu, Naijing Ye, Meisi Lin, et al.
Carbohydrate Polymers (2021) Vol. 273, pp. 118612-118612
Closed Access | Times Cited: 47
Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome
Yubiao Huang, Jiaqi Xu, Ge Sun, et al.
Biomaterials (2024) Vol. 314, pp. 122822-122822
Closed Access | Times Cited: 7
Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA
Jing Huang, Mengmeng Dai, Mingxia He, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4647-4662
Open Access | Times Cited: 11
The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease
Qiu‐Yu Li, Wenjuan Liu, Kaiheng Liu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 26, pp. 33081-33092
Closed Access | Times Cited: 4
Advanced polymeric systems for colon drug delivery: from experimental models to market applications
Ruben Crispino, Elena Lagreca, Antonio Procopio, et al.
Soft Matter (2025)
Closed Access
Nanotechnology-based drug delivery system for targeted therapy of Ulcerative colitis from traditional chinese medicine: A review
Chengcheng Gao, Z Yang, Ruirui Song, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125375-125375
Closed Access
Redox responsive poly(allylamine)/eudragit S-100 nanoparticles for dual drug delivery in colorectal cancer
Aastha Gupta, Ankur Sood, Ankita Dhiman, et al.
Biomaterials Advances (2022) Vol. 143, pp. 213184-213184
Closed Access | Times Cited: 14
Neuroprotective effects of Morinda officinalis How.: Anti-inflammatory and antioxidant roles in Alzheimer’s disease
Yi Zhang, Meng Zhang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 12
Dress me an outfit: advanced probiotics hybrid systems for intelligent IBD therapy
Yonglu Li, Yadi Wang, Yapeng Li, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-24
Closed Access | Times Cited: 2
The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis
Amira Motawea, Walaa Ebrahim Abd El Hady, Ghada Ahmed El-Emam
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 906-924
Open Access | Times Cited: 9
Recent advances in oral drug delivery materials for targeted diagnosis or treatment of gastrointestinal diseases
Songwei Huang, Cheng Zhou, Bensong Wang, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104903-104903
Closed Access | Times Cited: 4
Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1185-1185
Open Access | Times Cited: 1
Encapsulating products
Ana Paula da Fonseca Machado, Henrique Silvano Arruda, Lívia Mateus Reguengo, et al.
Elsevier eBooks (2023), pp. 319-364
Closed Access | Times Cited: 2
Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases
Milena Fronza Broering, Pedro Oseliero Filho, Pâmela Pacassa Borges, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3537-3554
Open Access
Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics
Shan Li, Tianyu Wu, Jingfeng Wu, et al.
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access
Application of Polymers as Drug Nanocarriers in the Oral Treatment of Ulcerative Colitis
Xiaoqing Liu, Lianghui Huang, Enguang Wu, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Closed Access
A Novel Mesalamine Loaded Hybrid Nanoparticle-in-Microparticle for Colon Targeting: In-vitro and In-vivo Investigations
Preety Gautam, Md Habban Akhter, Anubhav Anand
Journal of Pharmaceutical Innovation (2024) Vol. 19, Iss. 6
Closed Access
Page 1 - Next Page

Scroll to top